iCAD(ICAD)

Search documents
3 Top Small-Cap Growth Opportunities in the AI Era
investorplace.com· 2024-05-17 11:00
It's certainly a very good time to be in the AI business. After all, the technology has been getting huge amounts of positive publicity since December 2022, and it's being viewed as a powerful, helpful tool for humans. As a result, many AI stocks, such as Palantir (NYSE:PLTR), SoundhoundAI (NASDAQ:SOUN) and Nvidia (NASDAQ:NVDA), have skyrocketed. But there are still a multitude of small-cap AI stocks that are laboring in obscurity. These firms have all the advantages of being involved in AI, but their stock ...
iCAD(ICAD) - 2024 Q1 - Quarterly Results
2024-05-15 00:19
Exhibit 99.1 iCAD Reports Financial Results for First Quarter Ended March 31, 2024 NASHUA, N.H. – May 15, 2024 – iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can't hide by providing clinically proven AI-powered breast health solutions, today reported its financial and operating results for the three months ended March 31, 2024. First Quarter 2024 Highlights (Year over Year Performance): "Over the past year, we have demonstrated strong execution of our three-phased tr ...
iCAD(ICAD) - 2024 Q1 - Quarterly Report
2024-05-15 00:18
OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 Commission file number 001-09341 iCAD, Inc. (Exact name of registrant as specified in its charter) Delaware 02-0377419 (State or other ju ...
UPDATE - iCAD to Report First Quarter 2024 Financial Results on May 15, 2024
Newsfilter· 2024-05-08 13:49
NASHUA, N.H., May 08, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will release financial results for the first quarter ended March 31, 2024, pre-market and host a conference call at 8:30 AM Eastern Time on Wednesday, May 15, 2024. Earnings call details are as follows: Domestic: 877-545-0523International: 973-528-0016Participant Access Code: 730845Webcast: https://www.webcaster4.com/Webcast/Page/2879/50453 A ...
UPDATE - iCAD to Report First Quarter 2024 Financial Results on May 15, 2024
Globenewswire· 2024-05-08 13:49
NASHUA, N.H., May 08, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will release financial results for the first quarter ended March 31, 2024, pre-market and host a conference call at 8:30 AM Eastern Time on Wednesday, May 15, 2024. Earnings call details are as follows: Domestic: 877-545-0523International: 973-528-0016Participant Access Code: 730845Webcast: https://www.webcaster4.com/Webcast/Page/2879/50453 ...
iCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium
Newsfilter· 2024-04-11 12:00
ProFound Cloud, powered by Google Cloud architecture and Google's Health AI innovations, redefines accessibility to critical insights, empowering radiologists in early breast cancer detectionNew partnership with Densitas provides end-to-end breast health solution ensuring every aspect of a woman's breast health journey is addressedEnhanced ProFound Detection Workstation features streamline mammogram interpretation for radiologists NASHUA, N.H., April 11, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD), a ...
iCAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation
Newsfilter· 2024-04-09 12:00
Provides a holistic breast health solution, including breast cancer screening focused on quality, safety and efficiency, breast cancer detection, breast density assessment, and risk evaluationExpands access to iCAD's AI-powered ProFound Breast Health Suite and Densitas' AI solutions to patients and medical professionals worldwide NASHUA, N.H. and HALIFAX, Nova Scotia, April 09, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD), a global leader in clinically proven AI-powered cancer detection solutions, ann ...
iCAD(ICAD) - 2023 Q4 - Annual Report
2024-03-29 20:35
☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) Delaware 02-0377419 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 98 Spit Brook Road, Suite 100, Nashua, New Hampshire 03062 (Address of principal executive offices) (Zip Code) Registrant's telephone number, inclu ...
iCAD(ICAD) - 2023 Q4 - Annual Results
2024-03-12 20:05
Exhibit 99.1 iCAD Announces Fiscal Fourth Quarter and Full-Year 2024 Financial Results Annual Recurring Revenue of $8.7 million, an increase of 15% year-over-year Full-Year Operating Cash Flow ($5) million vs. ($12.8) million prior year Year ending cash balance of $21.7M NASHUA, N.H. – March 12, 2024 (GLOBE NEWSWIRE) -- a global leader in clinically proven AI-powered solutions that enable medical providers to accurately and reliably detect cancer earlier and improve patient outcomes, today announced results ...
iCAD(ICAD) - 2023 Q3 - Quarterly Report
2023-11-13 23:27
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-09341 iCAD, Inc. (Exact name of registrant as specified in its charter) Delaware 02-0377419 (State or othe ...